Jazz Pharmaceuticals (JAZZ) Misses Q3 EPS by 4c; Guides In-Line

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. S
10. COF

Go back to Jazz Pharmaceuticals (JAZZ) Misses Q3 EPS by 4c; Guides In-Line

BMO Capital Cuts Price Target on Jazz Pharmaceuticals (JAZZ) to $192

November 9, 2016 8:35 AM EST

BMO Capital maintained an Outperform rating on Jazz Pharmaceuticals (NASDAQ: JAZZ), and cut the price target to $192.00 (from $195.00), following the company's 3Q earnings report. Revenue was reported at $374mn, missing the consensus estimate of $389mn. While revenue fell short, it was mainly due... More